Julien Kirchgesner

Paris, 75012, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.

Journal: Journal of Crohn's & colitis

Published: July 22, 2026

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis

Published: July 08, 2026

Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis.

Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis.

Journal: Journal of Crohn's & colitis

Published: May 08, 2026

Benefit-risk balance of advanced therapies in pediatric inflammatory bowel disease: evidence and gaps versus adults.

Benefit-risk balance of advanced therapies in pediatric inflammatory bowel disease: evidence and gaps versus adults.

Journal: Inflammatory bowel diseases

Published: March 11, 2026

Clinical and radiologic predictors of one-year surgical outcomes in Crohn's disease-related intra-abdominal abscesses.

Clinical and radiologic predictors of one-year surgical outcomes in Crohn's disease-related intra-abdominal abscesses.

Journal: European journal of radiology open

Published: February 10, 2026

Methodological pitfalls in mild Crohn's disease clinical trials.

Methodological pitfalls in mild Crohn's disease clinical trials.

Journal: Med (New York, N.Y.)

Published: February 09, 2026

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 24, 2026

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal

Published: October 19, 2025

Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.

Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.

Journal: Clinics and research in hepatology and gastroenterology

Published: October 04, 2025

Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.

Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.

Journal: Journal of Crohn's & colitis

Published: September 10, 2025

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Journal: Clinical pharmacology and therapeutics

Published: September 04, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026